Philip J. Budge, MD, PhD
Associate Professor of Medicine
- Phone: 314-747-5198
- Fax: 314-454-5392
- Email: pbudge@nospam.wustl.edu
Dr. Budge specializes in translational, public health-related research, with a special focus on filarial infections—insect-borne threadlike parasitic worms that cause lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), and loiasis (African eye worm). Basic science work in the Budge lab aims to improve diagnostic tools for filarial infections through the identification of novel biomarkers. Clinical and epidemiologic research in Dr. Budge’s research group includes clinical trials of treatments for lymphatic filariasis, and validation of research tools for filarial infections. Key to this research are collaborations with international partners; the Budge lab is currently collaborating on clinical trials and/or field studies in Cameroon, Côte d’Ivoire, and Sri Lanka. Dr. Budge attends on the general ID consult service teaching fellows, residents, and students.
The Budge Lab welcomes fellows, residents, and students interested in parasitic and neglected tropical diseases.
Infectious Diseases Clinic
620 South Taylor Ave., Suite 100
St. Louis, MO 63110
- BS, Molecular Biology: Brigham Young University, Provo, UT (1998)
- Medical Degree: Vanderbilt University School of Medicine, Nashville, TN (2007)
- Epidemic Intelligence Service, Parasitic Diseases and Malaria: Centers for Disease Control and Prevention, Atlanta, GA (2011)
- PhD, Microbiology and Immunology: Vanderbilt University School of Medicine, Nashville, TN (2003)
- Residency, Internal Medicine: Vanderbilt University School of Medicine, Nashville, TN (2009)
- Fellowship, Infectious Diseases: Vanderbilt University School of Medicine, Nashville, TN (2014)
- American Board of Internal Medicine
- American Board of Internal Medicine, Subspecialty of Infectious Diseases
- Golden Pen Award, Florida Environmental Health Association (2012)
- Kirschstein National Research Service Award Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center (2013, 2014)
- Outstanding Fellow in Infectious Diseases, Vanderbilt University Medical Center (2014)
- Fellow, Infectious Diseases Society of America (FIDSA)
- Budge PJ, Bjerum CM, Ouattara AF, Fischer PU, Koudou GB. Moxidectin combination therapies for lymphatic filariasis-36-month follow-up. Lancet Infect Dis. 2025 Dec;25(12):e683. doi: 10.1016/S1473-3099(25)00625-5. Epub 2025 Oct 21. PubMed PMID: 41135533.select
- Koudou GB, Bjerum CM, Ouattara FA, Gabo TP, Goss CW, Lew D, Dje NN, King CL, Fischer PU, Weil GJ, Budge PJ. Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial. Lancet Infect Dis. 2025 Oct;25(10):1075-1083. doi: 10.1016/S1473-3099(25)00111-2. Epub 2025 May 6. PubMed PMID: 40345209.
- Pietrow RE, Bjerum C, Koudou BG, Supali T, Budge PJ, Fischer PU, Nutman TB, Bennuru S. Wb5, a novel biomarker for monitoring efficacy and success of mass drug administration programs for Wuchereria bancrofti elimination. PLoS Negl Trop Dis. 2025 May;19(5):e0013146. doi: 10.1371/journal.pntd.0013146. eCollection 2025 May. PubMed PMID: 40446061; PubMed Central PMCID: PMC12165424.